[Retracted] Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study

Table 4

Comparison of cellular immune indexes between groups ().

Grouping	N	CD4		CD8		CD3		CD4/CD8
		Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment
Observation group	72	36.31 ± 3.38	40.85 ± 4.14^a	28.45 ± 2.23	24.45 ± 2.67^a	59.64 ± 4.35	65.58 ± 6.25^a	1.23 ± 0.13	1.48 ± 0.12^a
Control group	72	36.37 ± 3.76	31.45 ± 3.05^b	28.23 ± 3.22	30.35 ± 2.83^b	59.48 ± 4.17	56.23 ± 5.24^b	1.21 ± 0.15	1.11 ± 0.15^b
t-value		0.101	15.511	0.477	12.867	0.199	9.728	0.855	16.344
P-value		＞0.05	＜0.05	＞0.05	＜0.05	＞0.05	＜0.05	＞0.05	＜0.05

Note. Compared to observation group before treatment, ^aP < 0.05. Compared to control group before treatment, ^bP < 0.05.